Abstract
Centers throughout North America are experiencing a remarkable rise in the proportion of newly diagnosed diabetic uremic patients requiring kidney replacement treatment [1–3]. Approximately 30% of all insulin-dependent (type I) diabetic patients die of renal failure. In the United States each year by conservative estimate, between 2,500 and 3,200 diabetics die of kidney disease [4]. Despite this large number, a decade ago diabetics with uremia comprised only 1–7% of all patients accepted for dialysis in Europe and the United States [5, 6]. These patients were excluded from dialysis for reasons that were multiple and complex, but the most important factors were the uniformly poor outcome of dialysis and transplantation [7–16], and the progressive deterioration of visual function. By 1978, however, due to technical advances in hemodialysis and better understanding of the factors contributing to the progression of diabetic complications, survival among chronically hemodialysed diabetics improved considerably [17–20].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Friedman EA. Where are the data on America’s uremic diabetics: Diabetic Nephropathy 2: 3, 1983.
E.S.R.D. Network dialysis and transplant survival data 1981. 1982.
1981 End Stage Renal Disease Annual Report to Congress. Health care financing administration, HCFA 82–02144.
Knowles HC. Magnitude of the renal failure problem in diabetic patients. Kidney Int 6 (SI): 2–7, 1976.
Drukker W, Haagsma-Schouten WAG, Alberts CHR, Baarda B. Report on regular dialysis treatment in Europe VI. Proc Euro Dial Transplant Assoc 6: 133–135, 1971.
Kjellstrand CM. Dialysis in diabetics. In: Strategy in Renal Failure, Friedman EA (ed). New York: J. Wiley & and Sons, 1977, pp. 345–391.
Abella R, et al. Periodic dialysis in terminal uremia. JAMA 199: 362–368, 1967.
Chazan BI, Rees SB, Balodimos MC, Younger D, Ferguson BD. Dialysis in diabetics: a review of 44 patients. JAMA 209: 2026–2030, 1969.
Blagg CR, Eschback JW, Sawyer TK, Casaretto AA. Dialysis for endstage diabetic nephropathy. Proc Eur Dial Transplant Forum 1: 133–135, 1971.
Comty CM, Shapiro FL. Management and prognosis of diabetic patients treated by chronic hemodialysis. Am Soc Nephrol 5: 15, 1971.
Ghavamian M, Gutch CF, Kopp KF, Kolff WJ. The sad truth about hemodialysis in diabetic nephropathy. JAMA 222: 1386–1389, 1972.
White N, Snowden SA, Parsons V, Sheldon J, Bewick M. The management of terminal renal failure in diabetic patients by regular dialysis therapy. Nephron 11: 261–275, 1973.
Leonard A, Comty C, Raij L, Rattazzi T, Wathen RS, Shapiro F. The natural history of regularly dialyzed diabetics. Trans Am Soc Artif Intern Organs 19: 282–286, 1973.
Ma KW, Masler DS, Brown DC. Hemodialysis in diabetic patients with chronic renal failure. Ann Int Med 83: 215–217, 1975.
Shideman JR, Buselmeier TJ, Kjellstrand CM. Hemodialysis complications in insulin dependent diabetic patient accepted for transplantation. Arch Intern Med 136: 1126–1130, 1976.
Avram MM, Slater PA, Fein PA, Altman E. Comparative survival of 673 patients with chronic uremia treated with renal transplantation (RT) and maintenance hemodialysis (MD). Trans Am Soc Artif Intern Organs 25: 391–393, 1979.
Comty C, Kuellsen D, Shapiro F. A reassessment of the prognosis of the diabetic patients treated by chronic hemodialysis. Trans Am Soc Artif Intern Organs 20: 286–296, 1978.
Ma K, Masler D, Brown D. Hemodialysis in diabetic patients with chronic renal failure. Ann Intern Med 83: 215–217, 1975.
Totten M, Izenstein B, Gleason R, et al. Chronic renal failure in diabetics. Survival with hemodialysis vs. transplantation. J Dial 2: 17–32, 1978.
Jacobs C, Rottembourg J, Frantz P, et al. Le traitment de l’insufficiance renale terminale du diabetique insulinodependent. In: Acutalitees Nephrologiques de L’Hopital Necker, Hamburger J, Grosnier J, Funk-Brentano J. (eds). Paris: Flammarion, 1978, p. 77.
Blumenkrantz M, Shapiro D, Mimura N, Oreopoulos DG, et al. Maintenance peritoneal dialysis as an alternative in the patients with diabetes mellitus and end stage uremia. Kidney Int (Suppl 1)6: 108–114, 1974.
Rubin J, Oreopoulos DG, Blair RG, et al. Chronic peritoneal dialysis in the management of diabetics with terminal renal failure. Nephron 19: 265–270, 1977.
Katirtzoglou A, Izatt S, Oreopoulos DG, et al. Chronic peritoneal dialysis in diabetics with end stage renal failure. In: Diabetic Renal-Retinal Syndrome, Friedman EA, et al. (eds). New York: Grune & Stratton, 19??, pp. 317–332.
Mitchell J, Fronhert P, Kurtz S, Anderson C. Chronic peritoneal dialysis in juvenile onset diabetes mellitus. A comparison with hemodialysis. Mayo Clinic Proc 53: 775–781, 1978.
Mion C. A peritoneal dialysis programme. Proc Eur Dial Transpl Assoc 12: 140, 1975.
Rubin J, Oreopoulos DG, Blair G, et al. Chronic peritoneal dialysis in the management of diabetics with terminal renal failure. Nephron 19: 265, 1977.
Blumenkrantz MJ, Kamdar AK, Coburn JW Peritoneal dialysis for diabetic patients with end stage nephropathy. Dial & Transpl 6: 47, 1977.
Blumenkrantz MJ, Shapiro DJ, Mimura, N, et al. Maintenance peritoneal dialysis as an alternative in the patient with diabetes mellitus and end-stage uremia. Kidney Int 1: S108, 1974.
Warden GS, Maxwell JG, Stephen RL. The use of reciprocating peritoneal dialysis with subcutaneous peritoneal catheter in end-stage renal failure in diabetes mellitus. J Surg Res 24: 495, 1978.
Mion C, Slingeneyer A, Selam JL, et al. Home peritoneal dialysis (HPD) in end-stage diabetic nephropathy (ESDN) (Abstr.). J Dial 2: 426, 1978.
Quellhorst E, Schuenemann B, Mutzsch G, Jacob I. Hemo and peritoneal dialysis treatment of patients with diabetic nephropathy. A comparison study. Proc Eur Dial Transpl Assoc 15: 205, 1978.
Ghantous WN, Adelson BH, Salkin MS, et al. A comparison of peritoneal and hemodialysis in the treatment of diabetic and end-stage renal failure (Abstr.). J Dial 2: 436, 1978.
Flynn CT, Nanson JA. Intraperitoneal insulin in diabetes. Lancet Sept. 15: 591, 1969.
Flynn CT, Nanson JA. Intraperitoneal insulin with CAPD—an artificial pancreas. Trans Am Soc Artif Intern Organs 25: 114–117, 1979.
Schade DS, Eaton RP. 1980. The peritoneum—a potential insulin delivery route for a mechanical pancreas. Diabetes Care 3: 229, 1980.
Oreopoulos DG, Khanna R, Williams P, Vas SI. Continuous ambulatory peritoneal—1981. Nephron 30: 293–303, 1982.
Nolph KD. Continuous ambulatory peritoneal dialysis. Am J Nephrol 1: 1–10, 1981.
Mion C, Slingeneyer A, Canaud B, Elie M. A review of seven years home peritoneal dialysis. Proc EDTA 18: 91–110, 1981.
Flynn T. Continuous ambulatory peritoneal dialysis in diabetic patients. Proceedings of the 1st International Symposium on CAPD. Excerpta Medica, Amsterdam 187, 1980.
Kuhlmann H, Thomae U. CAPD—an alternative in the dialysis treatment of diabetics suffering from kidney failure? Med Welt 31: 1140, 1980.
Amair P, Khanna R, Leibel B, et al. Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease. N Engl J Med 306: 625, 1982.
Flynn CT. Diabetes and CAPD. Int J Artif Organs 5, 332–333, 1982.
Legrain M, Rottembough J, Bentchikou A, et al. Dialysis treatment of insulin dependent diabetic patients: ten years experience. Clin Nephrology 21: 72–81, 1984.
Khanna R, Oreopoulos DG. Peritoneal access using the Toronto Western Hospital permanent catheter. Perspect Perit Dial 1; 4–7, 1983.
Khanna R Oreopoulos DG, Dombros N, et al. Continuous ambulatory peritoneal dialysis after three years: still a promising treatment. Perit Dial Bull 1: 24, 1981.
Porte D Jr, Bagdade JD. Human insulin secretion: an integrated approach. Annu Rev Med 21: 219–240, 1970.
Flynn CT Hibbard J, Dohrman B. Advantages of continuous ambulatory peritoneal dialysis to the diabetic with renal failure. Proc EDTA 16: 184–193, 1979.
Editorial. New insulin delivery system for diabetics. Lancet 1 (June): 1275–1277, 1979.
Greenwood RH, Davies CJ, Senator GB, et al. Intraperitoneal insulin in diabetics. Lancet 2: 312, 1979.
Flynn CT, Nanson JA. Intraperitoneal insulin in diabetics. Lancet 2: 591, 1979.
Graber AL. Chronic peritoneal dialysis in insulin dependent diabetes mellitus—diabetic clinical care conference. J Tenn Med Assoc 2: 74, 1981.
Schade DS, Eaton RP, et al. Five day programmed intraperitoneal insulin infusion in diabetic man. Abstract Am Diabetic Assoc, p. 71, 1980.
Schade DS, Eaton RP, Spencer W. The advantages of the peritoneal route of insulin delivery. In: Irsigler K., Kunz D., Owens, D., Regal, H. (Eds) New Approaches to Insulin Therapy. MTP Press, Lancaster 1981.
Zingg W, Shirriff JM, Liebel. Experimental routes of insulin administration. Perit Dial Bull 2: S24–27, 1982.
Balducci A, Slama G, Rottembourg J, Baumelou A, Delage A. Intraperitoneal insulin in uraemic diabetics undergoing continuous ambulatory peritoneal dialysis. Br Med J 283: 1021– 1023, 1981.
Shapiro DJ, Blumenkrantz MJ, Levin SR, Coburn JW. Absorption and action of insulin added to peritoneal dialysate in dogs. Nephron 23: 174–180, 1979.
Brachet E, Rasio E. The passage of (1251) insulin across isolated mensentery. Effect of anti-insulin serum, Biochim Biophys Acta., 183: 162–168, 1969.
Twardowski ZJ, et al. Insulin binding to plastic bags: a methodologic study. Am J Hosp Pharm 40: 575–579, 1983.
Twardowski ZJ, et al. Nature of insulin binding to plastic bags. Am J Hosp Pharm 40: 579–582, 1983.
Twardowski ZJ, et al. Influence of temperature and time on insulin adsorption to plastic bags. Am J Hosp Pharm 40: 583–586, 1983.
Twardowski ZJ Insulin adsorption to peritoneal dialysis bags. Perit Dial Bull 3: 113–115, 1983.
Johnson CA, et al. Adsorption of insulin to the surface of peritoneal dialysis solution containers. Am J Kidney Disease 3: 224–228, 1983.
Silver MR, Sorkin MI. Insulin delivery from continuous ambulatory peritoneal dialysis bags used with peridex filters. Perit Dial Bull 4: 23–27, 1984.
Blumenkrantz MJ, Salehmghaddan S, Salusky I. Treatment of patients with end-stage diabetic nephropathy. In: Peritoneal Dialysis, LaGreca G, et al. (eds). Milano, Italy: Wichtig, Editor, 1983, pp. 289–306.
Khanna R, Liebel B. The Toronto Western Hospital protocol. What is the protocol for control of blood sugar in diabetics on CAPD? Perit Dial Bul 1: 100–101, 1981.
Rottembourg J, Caryon A, Benoliel D, Pelluzo F, Ozzanne P. Critical evaluation of the injection site for insulin in CAPD diabetic patient. Perit Dial Bull 4: S55, 1984.
Reeves ML, Forhan SE, Skyler JS, Peterson CM. Comparison of methods for blood glucose monitoring. Diabetes Care 4: 404–406, 1980.
Khanna R, Wu G, Chisholm L, Oreopoulos DG. Further experience with CAPD in diabetics with end-stage renal disease. In: Prevention and Treatment of Diabetic Nephropathy, Keen H, Legrain M. (eds). Boston: MTP Press Limited, 1983, pp. 279–288.
Lameire N, Dhaene M, Matthigs E, et al. Experience with CAPD in diabetic patients. In: Prevention and Treatment of Diabetic Nephropathy, Keen H, Legrain M. (eds). Boston: MTP Press Limited, 1983, pp. 289–297.
Coronel F, Naranjo P, Prats D. A year of experience of CAPD in the diabetic and non-diabetic patient. In: Prevention and Treatment of Diabetic Nephropathy, Keen H, Legrain M. (eds). Boston: MTP Press Limited, 1983, pp. 315–332.
Grefberg N, Danielson BG, Nilsson P. Continuous ambulatory peritoneal dialysis in the treatment of end-stage diabetic nephropathy. Acta Medica Scand 215: 427–434, 1984.
Rottembourg J, Shahat EL, Agrafiotis A, et al. CAPD in insulin dependent diabetic patients, and a 40 month experience. Kidney Int 23: 40, 1983.
Graft RJ, Porte DJ. Glycosylated hemoglobin as an index of glycemia independent of plasma insulin in normal and diabetic subjects. Diabetes 27: 368, 1977.
Boer MJ, Miedema K, Casparie AF. Glycosylated hemoglobin in renal failure. Diabetologia 18: 437–440, 1980.
Serkes K. Travenol Laboratories, Deerfield, Illinois, Personal communication.
Popovich RP, Moncrief JW, Nolph KD, et al. Continuous ambulatory peritoneal dialysis. Ann Intern Med 88: 449, 1978.
Oreopoulos DG, Robson M, Izatt S, et al. A simple and safe technique for continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs, 1978, pp. 484–487.
Slingeneyer A, Mion C, Despaux E, et al. Use of bacteriologic filter in the prevention of peritonitis associated with peritoneal dialysis: long-term clinical results in intermittent and continuous ambulatory peritoneal dialysis. In: Peritoneal Dialysis, Atkins RC, et al. (eds). Edinburgh: Churchill Livingston, 1981, pp. 114–125.
Oreopoulos DG, Zellerman G, Izatt S. The Toronto Western Hospital permanent peritoneal catheter and continuous ambulatory peritoneal dialysis connector. In: Continuous Ambulatory Peritoneal Dialysis, Legrain M. (ed). Amsterdam: Excerpta Medica, 1980, pp. 73–78.
Williams C, and the University of Toronto Collaboratory Dialysis Group. CAPD in Toronto —an overview. Perit Dial Bull 35: 2–6, 1983.
Flynn CT. The diabetic patient on continuous ambulatory peritoneal dialysis. Perit Dial Bull 351: 16–20, 1983.
Slingeneyer A, Mion C, Selam JL. Home intermittent and CAPD as a long term treatment of end-stage renal failure in diabetics. In: Advances in Peritoneal Dialysis, Gahl GM, et al. (eds). Amsterdam: Excerpta Medica, 1981, pp. 378–388.
Grefberg N. Clinical aspects of continuous ambulatory peritoneal dialysis. Scand J Uro, Nephrol 72: S7 - 38, 1983.
Madden MA, Zimmerman SW, Simpson DP CAPD in diabetes mellitus. Am J Nephrol 2: 133–139, 1982.
Ponce SP, et al. Comparison of the survival and complications of the permanent peritoneal dialysis catheters. Perit Dial Bull 2: 82, 1982.
Dombros N, Oven A, Marliss EB, et al. Plasma amino acid profiles and amino acid losses in patients undergoing CAPD. Perit Dial Bull 2: 27 - 32, 1982.
Giordano C, DeSanto NG, Capodicase G, et al. Amino acid losses during CAPD. Clin Nephrol 14: 230–232, 1980.
Randerson D, Chapman GV, Farrel PC. Amino acid and dietary status in CAPD patients. In:Peritoneal Dialysis, Atkins RC, et al. (eds). New York: Churchill Livingston, 1981, pp. 179–191.
Moncrief JW, Pyle WK, Simon P, Popovich RP. Hypertriglyceridemia, diabetes mellitus, and insulin administration in patients undergoing CAPD. In: CAPD Update, Moncrief J W, et al. (eds). New York: Mason Publishing, 1981, pp. 143–165.
Beardsworth SF, Goldsmith HJ, Stanbridge BR. Intraperitoneal insulin cannot correct the hyperlipidemia of CAPD. Perit Dial Bull 3: 126–128, 1983.
Khanna R, Breckenridge C, Roncari D, Digenis G, Oreopoulos DG. Lipid abnormalities in patients undergoing continuous ambulatory peritoneal dialysis. Perit Dial Bull 35: 13–15, 1983.
Faller B, Marichal JD. Loss of ultrafiltration in CAPD. Clinical data. In: Advances in Peritoneal Dialysis, Gahl G, Kessel M, Nolph KD. (eds). Amsterdam: Exerpta Medica, 1981, pp. 227–232.
Slingeneyer A, Canaud B, Mion C. Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis. Nephron 33: 133–138, 1983.
Rottembourg J, Issad B, Poignet JL, et al. Residual renal function and control of blood glucose levels in insulin-dependent diabetic patients treated by CAPD. In: Prevention and Treatment of Diabetic Nephropathy, Keen H, Legrain M. (eds). Boston: MTP Press Ltd, 1983, pp. 339–352.
Shapiro FL, Comty CM. Hemodialysis in diabetics—1981 update. In: Diabetic Renal—Retinal Syndrome, Friedman EA, et al. (eds). New York: Grune & Stratton, 1982, pp. 309 - 320.
Kurtz SB, Wong VH, Anderson CF, et al. Continuous ambulatory peritoneal dialysis. Three years experience at the Mayo Clinic. Mayo Clinic Proc 58: 633–639, 1983.
Nolph KD, et al. Personal communication.
Wing AF, Broyer M, Brunner FP, et al. Combined report on regular dialysis and transplantation in Europe 1982. Proc EDTA, ERA, 1983. 20: 1–78, 1983.
Flynn CT. The diabetics on CAPD. In: Diabetic Renal-Retinal Syndrome, Friedman EA, et al. (eds). New York: Grune and Stratton, 1983, pp. 321–330.
Doughty MC, Pierie KG. Continuous ambulatory peritoneal dialysis and the blind patient. Nephrol Nurse 3: 11, 1981.
Knotek B. Independence for the visually impaired continuous ambulatory peritoneal dialysis (CAPD) patient. AANNT J 9: 69–71, 1982.
Kelman B. Diabetes and the blind new methods. New treatments. Renal Family: 35–41, 1983.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Khanna, R., Oreopoulos, D.G. (1986). Continuous Ambulatory Peritoneal Dialysis in End-Stage Diabetic Nephropathy. In: Friedman, E.A., Peterson, C.M. (eds) Diabetic Nephropathy. Developments in Nephrology, vol 9. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2287-0_7
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2287-0_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9410-8
Online ISBN: 978-1-4613-2287-0
eBook Packages: Springer Book Archive